Aarhus University Seal / Aarhus Universitets segl

Kristian Stengaard-Pedersen

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2 year randomized controlled trial (CIMESTRA)

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Merete Lund Hetland, Denmark
  • Bo Jannik Ejbjerg, Denmark
  • Kim Hørslev-Petersen, Denmark
  • Søren Jacobsen, Denmark
  • Aage Vestergaard, Denmark
  • Anne Grethe Jurik
  • Kristian Stengaard-Pedersen
  • Peter Junker, Denmark
  • Tine Lottenburger, Denmark
  • Ib Hansen
  • Lis Smedegaard Andersen, Denmark
  • Ulrik Tarp, Denmark
  • Henrik Skjødt, Denmark
  • Jens K Pedersen, Denmark
  • Ole Majgaard, Denmark
  • Anders J Svendsen, Denmark
  • Torkell Ellingsen, Denmark
  • Hanne M Lindegaard, Denmark
  • Anne F Christensen, Denmark
  • Jørgen Vallø, Denmark
  • Trine Torfing, Denmark
  • Eva Narvestad, Denmark
  • Henrik S Thomsen, Denmark
  • Mikkel Ostergaard, Denmark
  • Diagnostic Radiology
  • The Section for Rheumatology
OBJECTIVE: To identify predictors of radiographic progression in a 2-year randomized, double-blind clinical study (CIMESTRA) of patients with early rheumatoid arthritis (RA). METHODS: Early RA patients (N=130) were treated with methotrexate, intra-articular betamethasone and cyclosporine/placebo-cyclosporine. Baseline magnetic resonance imaging (MRI) of the wrist (wrist-only-group:N=130) or MRI of wrist and MCP-joints (wrist+MCP-group:N=89) (OMERACT RAMRIS), x-rays of hands, wrists and forefeet (Sharp/vdHeijde Score (TSS)), disease activity score (DAS28), anti-cyclic-citrullinated-peptide-antibodies (anti-CCP), HLA-DRB1-shared-epitope (SE) and smoking status were assessed. Multiple regression analysis was performed with delta-TSS (0-2 years) as dependent variable, and baseline DAS28, TSS, MRI bone oedema score, MRI synovitis score, MRI erosion score, anti-CCP, smoking, SE, age and gender as explanatory variables. RESULTS: Baseline values: median DAS28: 5.6 (range: 2.4-8.0); anti-CCP positive: 61%; radiographic erosions: 56%. At 2 years: DAS28: 2.0 (0.5-5.7), in DAS-remission: 56%, radiographic progression: 26% (wrist+MCP-group, similar for wrist-only-group). MRI bone oedema score was the only independent predictor of delta-TSS (wrist+MCP-group: coefficient=0.75 (95%CI: 0.56-0.97), p<0.00001; wrist-only-group: coefficient=0.56 (0.41-0.77), p<0.00001). Bone oedema score explained 41% of the variation in the progression of TSS (wrist+MCP-group), 25% in wrist-only-group, (Pearson's r=0.64 and r=0.50, respectively). The results were confirmed by sensitivity analyses. CONCLUSION: In a RCT aiming at remission in early RA patients, baseline RAMRIS MRI bone oedema score of MCP and wrist joints (and of wrist only) was the strongest independent predictor of radiographic progression in hands, wrists and forefeet after 2 years. MRI synovitis score, MRI erosion score, DAS28, anti-CCP, SE, smoking, age and gender were not independent risk factors.
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
ISSN0003-4967
DOIs
Publication statusPublished - 2008

See relations at Aarhus University Citationformats

ID: 15167656